Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added an important government-operating-status notice and a new version tag v3.2.0; removed the old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T15:58:42.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:51:17.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page updates from v3.0.1 to v3.0.2, with the Back to Top element removed; no substantive changes to core content or pricing are indicated.
    Difference
    0.1%
    Check dated 2025-09-14T23:48:21.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-07T20:30:56.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms and drug names related to ovarian cancer treatment. Notably, the revision number has been updated to v3.0.0.
    Difference
    6%
    Check dated 2025-08-31T12:53:52.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.6%
    Check dated 2025-08-17T05:14:25.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.